Joe Guzman is a co-founder of Indianapolis-based Ascend USA, the new trade adopted after Guzman merged his
benefits brokerage, Benefits Strategies Inc., with benefits business Steven Goodin. The eight-person firm expects to hire
as many 15 new employees in the next year. Those workers will help Ascend diversify from health benefits into brokering commercial
insurance products.
The U.S. Food and Drug Administration last week pushed its self-declared deadline for rendering an approval decision on the
drug Bydureon to Oct. 22. The previous deadline was in March.
As physician mergers increase in Indianapolis, a new study has determined that quality at large, multispecialty practices is at
least 5 percent higher and costs are 3.6 percent lower than at small group practices.
Carmel-based life and health insurer is now CNO Financial Group Inc. to reflect what company officers call a “transformation”
of the once-troubled firm.
The U.S. health overhaul’s mandate that insurers spend 80 percent of premiums on medical care may
need to be loosened
to keep companies from quitting the market for people who buy coverage on their own, state regulators said.
The health law passed by Congress in March will force insurers like WellPoint to give rebates to customers next year if the
companies don’t meet the medical-spending minimums.
CEO of Indianapolis-based health insurer wrote to Obama on Sunday to rebut the president’s criticism that WellPoint seeks
out breast cancer patients to cancel their policies.
The lawsuit filed this week in Marion Superior Court claims Clarian Health charges uninsured patients—or those receiving
treatments not covered by their insurance—unreasonably high prices.
Indianapolis-based drugmaker Eli Lilly and Co. is on course to cut 5,500 jobs by the end of 2011 in a bid to eliminate $1
billion in annual expenses.
Elanco Animal Health chief Jeff Simmons predicts that consumers will opt for food made cheaper by using
Elanco’s productivity-enhancing drugs over pricier organic and locally grown products. But, as a hedge,
he has Elanco developing products to help organic farmers, too.
Bloomington led the nation as the No. 1 small city in medical devices and equipment.
The deal included a $296 million criminal fine, but no charges against executives who failed to properly report problems with the company's defibrillators.
Groundbreaking will be held May 16 to mark start of construction on center to be built on 300-acre campus.
The new home for the Eugene and Marilyn Glick Eye Institute that’s rising from the ground at IUPUI must do a lot
of things well.
There has been a noticeable uptick in the level of health care real estate development activity this year.
The Obama administration has asked state regulators to double-check premium hikes from Indianapolis-based health insurer WellPoint
Inc. after an audit found problems with proposed California increases.
Replacing the existing Wishard Memorial Hospital is so critical to the well-being of the sickly construction sector that one
industry official likens the project to a "lifeline."
Watson Pharmaceuticals filed for FDA approval to sell a low-cost version of Eli Lilly and Co.’s osteoporosis medicine. Indianapolis-based
Lilly is seeking a court order that would block approval until three of its patents expire in 2017.
Clarian will become Indiana University Health early next year in a bet the IU brand carries more punch statewide and nationally.
The Indianapolis-based hospital system, which has 16 hospitals as far afield as LaPorte, Hartford City and Paoli, can
now associate with all its facilities the name of the school that trains the majority of doctors and nurses throughout the
state.
